Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the anti-tumor activity of LY2181308 in combination
with docetaxel compared to docetaxel alone in participants with non-small cell lung cancer
who were previously treated with first line chemotherapy.